ARTICLE | Company News
Aptalis Holdings, Forest Laboratories deal
January 13, 2014 8:00 AM UTC
Forest will acquire gastrointestinal company Aptalis for $2.9 billion in cash. Aptalis markets nine products, including Carafate sucralfate suspension to treat active duodenal ulcers and Zenpep panc...